Hmm I'm not convinced the issue here is simply lack of investor awareness. It is fairly clear that the trial is very likely to be successful but so what? There was already plenty of evidence of efficacy. Perhaps the market is skeptical about the commercial potential of the drug?
would be nice to see a little more push from management, page-16
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
